To compare the clinical effects of minimally invasive removal of intracranial hematoma and craniotomy in the treatment of hypertensive cerebral hemorrhage.

A total of 236 patients with hypertensive cerebral hemorrhage treated in Zhumadian First People’s Hospital from January 2015 to July 2021 were retrospectively analyzed. Among them, 124 patients who underwent craniotomy in the hospital from January 2015 to July 2018 were selected as the craniotomy group, and 112 patients who underwent minimally invasive removal of intracranial hematoma from August 2018 to July 2021 were selected as the minimally invasive group. Clinical effects, perioperative conditions, intracranial pressure (ICP) and Fugl-Meyer assessment (FMA) scores, the American National Institute of Health Stroke Scale (NIHSS) score, Barthel index (BI) score and incidence of complications were compared between the two groups.

The total effective rate in minimally invasive group was 90.18%(101/112), which was higher than the 79.84% (99/124) in craniotomy group (P<0.05). The time of hematoma disappearance, operation time and hospital stay in minimally invasive group were shorter than those in craniotomy group (all P<0.05). The FMA score of minimally invasive group was higher than that of craniotomy group (P<0.05). After treatment, NIHSS score in the minimally invasive group was lower, and BI score was higher, compared with those in the craniotomy group (P<0.05). There was no significant difference in complication rate between minimally invasive group (9.82%, 11/112) and craniotomy group (12.10%, 15/124), P>0.05.

Compared with craniotomy, minimally invasive removal of intracranial hematoma for patients with cerebral hypertensive hemorrhage can improve the therapeutic effect, improve the perioperative situation, restore upper limb function, nerve function, enhance their self-care ability, with low rate of complications.

Cerebral hemorrhage; Hypertensive minimally invasive removal of intracranial hematoma; Craniotomy; Nerve function